StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:52 UTC

HALO — Halozyme Therapeutics, Inc.

FAIR (MOS +20.9%) · Quality 100/100

Price
112.45
Intrinsic value
142.13
Margin of safety
+20.9%
Implied growth (reverse DCF)
+8.5%
model assumes +12.0%
Value Score
43.3
Quality
100
Psychology
-39.2
Discovery
54.6
price/volume attention only
Moat score
85.8
erosion: none

Value Score: top 34% of Russell 3000 · Quality: top 1%

Open the interactive Deep Dive for HALO →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/HALO - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is HALO undervalued?

As of 2026-09-19, HALO trades at 112.45 against a computed intrinsic value of 142.13 (+20.9% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is Halozyme Therapeutics, Inc.'s Value Score?

Halozyme Therapeutics, Inc.'s Value Score is 43.3 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.